Physician profile
John R Gwin
NPI 1568542173
$3,853.14
in general payments reported to CMS, 2019-2025
17 companies · $627 in 2025
The $627 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $469 · 2020: $116 · 2021: $543 · 2022: $799 · 2023: $457 · 2024: $843 · 2025: $627.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,912 · Entertainment: $14.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,911.98 |
| Entertainment | $14.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,239.23 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $1,137.58 | 2019-2025 | Dailies Total1, Hydrus Microstent, Precision 1 |
| Biotissue Holdings INC. | $404.44 | 2022-2025 | |
| Oyster Point Pharma, INC. | $177.42 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Sun Pharmaceutical Industries INC. | $164.59 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $135.80 | 2019-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $107.38 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $91.36 | 2024-2025 | Xdemvy |
| Quidel Corporation | $80.80 | 2019 | |
| Abbvie INC. | $77.03 | 2022-2025 | |
| Kala Pharmaceuticals, INC. | $63.22 | 2021-2022 | |
| Bausch & Lomb Americas INC. | $49.95 | 2023-2025 | Xiidra, Infuse, Miebo |
| Sight Sciences, INC. | $41.85 | 2022-2024 | Tearcare System |
| Coopervision INC. | $35.14 | 2021-2024 | Myday Contact Lens |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $14.15 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Shire North American Group INC | $13.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Gwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.